Swiss medtech company Bloom Diagnostics announced European approval for its Bloom Ovarian Reserve Test, measuring AMH (Anti-Müllerian Hormone) using their Bloom System, at-home or in a professional ...
NIH Grants 23andMe $1.4 Million for Genetics Research The Food and Drug Administration (FDA) has approved for marketing 23andMe's Bloom Syndrome carrier test to determine whether a healthy person ...
Swiss medtech company Bloom Diagnostics has announced the launch of the Bloom Inflammation Test, designed to test for the quantitative measurement and presence of the C-Reactive Protein (CRP) using ...
The FDA has granted 23andMe authority for marketing a direct-to-consumer genetic test, nearly a year and a half after forcing the company to stop selling its Saliva Collection Kit and Personal Genome ...